|
|
Volumn 286, Issue 12, 2001, Pages 1445-1446
|
|
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in american thoracic society/CDC recommendations - United States, 2001
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ADULT;
AGED;
CLINICAL ARTICLE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG MONITORING;
DRUG SAFETY;
FEMALE;
HUMAN;
LIVER INJURY;
LIVER TOXICITY;
MALE;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
TUBERCULOSIS;
ARTICLE;
DRUG COMBINATION;
MIDDLE AGED;
MORTALITY;
TOXIC HEPATITIS;
ADULT;
AGED;
ANTITUBERCULAR AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS, TOXIC;
HUMANS;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINES;
PYRAZINAMIDE;
RIFAMPIN;
TUBERCULOSIS;
|
|
EID: 0035955027
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.286.12.1445 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|